PetMed Express, Inc. (NASDAQ:PETS) Shares Sold by Charles Schwab Investment Management Inc.

Charles Schwab Investment Management Inc. cut its holdings in PetMed Express, Inc. (NASDAQ:PETSFree Report) by 46.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 109,186 shares of the company’s stock after selling 96,449 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in PetMed Express were worth $526,000 as of its most recent filing with the SEC.

Separately, R Squared Ltd purchased a new position in shares of PetMed Express during the fourth quarter worth about $31,000. 73.33% of the stock is currently owned by institutional investors and hedge funds.

PetMed Express Price Performance

NASDAQ:PETS opened at $4.19 on Tuesday. The firm has a market cap of $86.55 million, a price-to-earnings ratio of 419.42 and a beta of 0.78. PetMed Express, Inc. has a 1-year low of $2.90 and a 1-year high of $6.85. The firm’s fifty day moving average price is $4.46 and its 200 day moving average price is $4.54.

PetMed Express (NASDAQ:PETSGet Free Report) last issued its earnings results on Monday, February 10th. The company reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.02). PetMed Express had a net margin of 0.14% and a return on equity of 0.37%. As a group, analysts expect that PetMed Express, Inc. will post 0.19 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, StockNews.com downgraded PetMed Express from a “buy” rating to a “hold” rating in a research note on Tuesday, February 11th.

Check Out Our Latest Research Report on PetMed Express

PetMed Express Company Profile

(Free Report)

PetMed Express, Inc, together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and household pet supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes.

Recommended Stories

Want to see what other hedge funds are holding PETS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for PetMed Express, Inc. (NASDAQ:PETSFree Report).

Institutional Ownership by Quarter for PetMed Express (NASDAQ:PETS)

Receive News & Ratings for PetMed Express Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PetMed Express and related companies with MarketBeat.com's FREE daily email newsletter.